Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The Fabry disease-causing mutation, GLA IVS4+919G>A, originated in Mainland China more than 800 years ago

Journal of Human Genetics volume 65, pages 619–625 (2020)Cite this article

Subjects

Abstract

The Fabry disease-causing mutation, the GLA IVS4+919G>A (designated GLA IVS4), is very prevalent in patients with hypertrophic cardiomyopathy in Taiwan. This X-linked mutation has also been found in patients in Kyushu, Japan and Southeast Asia. To investigate the age and the possible ancestral origin of this mutation, a total of 33 male patients with the GLA IVS4+919G>A mutation, born in Taiwan, Japan, Singapore, Malaysia, Vietnam, and the Fujian and Guangdong provinces of China, were studied. Peripheral bloods were collected, and the Ilumina Infinium CoreExome-24 microarray was used for dense genotyping. A mutation-carrying haplotype was discovered which was shared by all 33 patients. This haplotype does not exist in 15 healthy persons without the mutation. Rather, a wide diversity of haplotypes was found in the vicinity of the mutation site, supporting the existence of a single founder of the GLA IVS4 mutation. The age of the founder mutation was estimated by the lengths of the mutation-carrying haplotypes based on the linkage-disequilibrium decay theory. The first, second, and third quartile of the age estimates are 800.7, 922.6, and 1068.4 years, respectively. We concluded that the GLA IVS4+919G>A mutation originated from a single mutational event that occurred in a Chinese chromosome more than 800 years ago.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Desnick RJ. Fabry disease (α-galactosidase A deficiency). In: Encyclopedia of genetics. Berkeley: Elsevier; 2001. p. 681.

  2. Germain DP. Fabry disease. Orphanet J Rare Dis. 2010;5:30. https://doi.org/10.1186/1750-1172-5-30.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Desnick RJ. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003;138:338. https://doi.org/10.7326/0003-4819-138-4-200302180-00014.

    Article  PubMed  Google Scholar 

  4. Nakao S, Kodama C, Takenaka T, Tanaka A, Yasumoto Y, Yoshida A, et al. Fabry disease: detection of undiagnosed hemodialysis patients and identification of a “renal variant” phenotype1. Kidney Int. 2003;64:801–7. https://doi.org/10.1046/j.1523-1755.2003.00160.x.

    Article  PubMed  Google Scholar 

  5. Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, et al. An atypical variant of Fabry’s disease in men with left ventricular hypertrophy. N Engl J Med. 1995;333:288–93. https://doi.org/10.1056/nejm199508033330504.

    Article  CAS  PubMed  Google Scholar 

  6. Wv Scheidt, Eng CM, Fitzmaurice TF, Erdmann E, Hübner G, EGJ Olsen, et al. An atypical variant of Fabry’s disease with manifestations confined to the myocardium. N Engl J Med. 1991;324:395–9. https://doi.org/10.1056/nejm199102073240607.

    Article  Google Scholar 

  7. Desnick RJ, Brady RO. Fabry disease in childhood. J Pediatrics. 2004;144:S20–S6. https://doi.org/10.1016/j.jpeds.2004.01.051.

    Article  Google Scholar 

  8. Lin H-Y, Chong K-W, Hsu J-H, Yu H-C, Shih C-C, Huang C-H, et al. High incidence of the cardiac variant of Fabry disease revealed by newborn screening in the Taiwan Chinese population. Circ Cardiovasc Genet. 2009;2:450–6. https://doi.org/10.1161/circgenetics.109.862920.

    Article  PubMed  Google Scholar 

  9. Hsu T-R, Hung S-C, Chang F-P, Yu W-C, Sung S-H, Hsu C-L, et al. Later onset Fabry disease, cardiac damage progress in silence. J Am Coll Cardiol. 2016;68:2554–63. https://doi.org/10.1016/j.jacc.2016.09.943.

    Article  PubMed  Google Scholar 

  10. Ishii S, Nakao S, Minamikawa-Tachino R, Desnick RJ, Fan J-Q. Alternative splicing in the α-galactosidase A gene: increased exon inclusion results in the Fabry cardiac phenotype. Am J Hum Genet. 2002;70:994–1002. https://doi.org/10.1086/339431.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Chang W-H, Niu D-M, Lu C-Y, Lin S-Y, Liu T-C, Chang J-G. Modulation the alternative splicing of GLA (IVS4+919G>A) in Fabry disease. PLOS One. 2017;12:e0175929. https://doi.org/10.1371/journal.pone.0175929.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Lin H-Y, Liu H-C, Huang Y-H, Liao H-C, Hsu T-R, Shen C-I, et al. Effects of enzyme replacement therapy for cardiac-type Fabry patients with a Chinese hotspot late-onset Fabry mutation (IVS4+919G>A). BMJ Open. 2013;3:e003146. https://doi.org/10.1136/bmjopen-2013-003146.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Niu D-M, Yu W-C, Hsu T-R, Chang F-P, Sung S-H, Chu T-H. When is the best time to start enzyme replacement therapy in patients with cardiac-type Fabry disease? Experience from Taiwan, an area highly prevalent in this cardiac phenotype. Mol Genet Metab. 2015;114:S87–S8. https://doi.org/10.1016/j.ymgme.2014.12.194.

    Article  Google Scholar 

  14. Gandolfo LC, Bahlo M, Speed TP. Dating rare mutations from small samples with dense marker data. Genetics. 2014;197:1315–27. https://doi.org/10.1534/genetics.114.164616.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Efron B. Bootstrap methods: another look at the Jackknife, Springer series in statistics. New York: Springer; 1992. p. 569–93.

    Google Scholar 

  16. Carriço JA, Crochemore M, Francisco AP, Pissis SP, Ribeiro-Gonçalves B, Vaz C. Fast phylogenetic inference from typing data. Algorithms Mol Biol. 2018;13. https://doi.org/10.1186/s13015-017-0119-7.

  17. Altshuler D, Gibbs R, Peltonen L, Altshuler DM, Gibbs RA, Peltonen L, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467:52–8.

    Article  CAS  Google Scholar 

  18. Kanzawa-Kiriyama H, Jinam TA, Kawai Y, Sato T, Hosomichi K, Tajima A, et al. Late Jomon male and female genome sequences from the Funadomari site in Hokkaido, Japan. Anthropological Sci. 2019;127:83–108. https://doi.org/10.1537/ase.190415.

    Article  Google Scholar 

  19. Choi J-H, Lee BH, Heo SH, Kim G-H, Kim Y-M, Kim D-S, et al. Clinical characteristics and mutation spectrum of GLA in Korean patients with Fabry disease by a nationwide survey. Medicine. 2017;96:e7387. https://doi.org/10.1097/md.0000000000007387.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Tadaka S, Katsuoka F, Ueki M, Kojima K, Makino S, Saito S, et al. 3.5KJPNv2: an allele frequency panel of 3552 Japanese individuals including the X chromosome. Hum Genome Var. 2019;6. https://doi.org/10.1038/s41439-019-0059-5.

  21. Dreyer EL. Japanese piracy in Ming China during the 16th Century. By Kwan-Wai So. East Lansing: Michigan State University Press, 1975. x, 254 pp. J Asian Stud. 1976;36:129–30. https://doi.org/10.1017/s002191180007902x.

Download references

Acknowledgements

The authors would like to thank Wen-Ya Ko for his professional advices in population genetics, as well as the journal reviewer #2 for the comprehensive guidance in the presentation of the manuscript.

Funding

This work was partly supported by the Ministry of Science and Technology, Taiwan (grant number 108-2321-B-075-003).

Author information

Author notes

  1. These authors contributed equally: Kung-Hao Liang, Yung-Hsiu Lu

Authors and Affiliations

  1. Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan

    Kung-Hao Liang

  2. Institute of Biomedical Informatics, National Yang-Ming University, Taipei, Taiwan

    Kung-Hao Liang

  3. Institute of Food Safety and Health Risk Assessment, National Yang-Ming University, Taipei, Taiwan

    Kung-Hao Liang

  4. Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan

    Yung-Hsiu Lu, Chih-Wei Niu, Sheng-Kai Chang, Yun-Ru Chen, Chih-Ya Cheng, Ting-Rong Hsu, Chia-Feng Yang & Dau-Ming Niu

  5. Department of Pediatrics, Kumamoto University, Kumamoto, Japan

    Kimitoshi Nakamura

  6. Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan

    Dau-Ming Niu

Authors
  1. Kung-Hao Liang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yung-Hsiu Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chih-Wei Niu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sheng-Kai Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yun-Ru Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chih-Ya Cheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ting-Rong Hsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Chia-Feng Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kimitoshi Nakamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Dau-Ming Niu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Kimitoshi Nakamura or Dau-Ming Niu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liang, KH., Lu, YH., Niu, CW. et al. The Fabry disease-causing mutation, GLA IVS4+919G>A, originated in Mainland China more than 800 years ago. J Hum Genet 65, 619–625 (2020). https://doi.org/10.1038/s10038-020-0745-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-020-0745-7

Search

Advanced search

Quick links